UNLV Theses, Dissertations, Professional Papers, and Capstones
5-1-2021

Opioid and Naloxone Training in a Rural School District
Allyson C. Waldron

Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations
Part of the Medical Pharmacology Commons, Nursing Commons, Pharmacology Commons,
Pharmacy and Pharmaceutical Sciences Commons, and the Public Health Commons

Repository Citation
Waldron, Allyson C., "Opioid and Naloxone Training in a Rural School District" (2021). UNLV Theses,
Dissertations, Professional Papers, and Capstones. 4217.
http://dx.doi.org/10.34917/25374118

This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital
Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that
is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to
obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons
license in the record and/or on the work itself.
This Dissertation has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and
Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact
digitalscholarship@unlv.edu.

OPIOID AND NALOXONE TRAINING IN A RURAL SCHOOL DISTRICT

By
Allyson C. Waldron

Bachelor of Science - Nursing
Great Basin College
2017
A doctoral project submitted in partial fulfillment
of the requirements for the
Doctor of Nursing Practice

School of Nursing
The Graduate College
University of Nevada, Las Vegas
May 2021

Copyright 2021 Allyson Waldron
All Rights Reserved

Doctoral Project Approval
The Graduate College
The University of Nevada, Las Vegas

March 19, 2021

This doctoral project prepared by

Allyson C. Waldron

entitled

Opioid and Naloxone Training in a Rural School District

is approved in partial fulfillment of the requirements for the degree of

Doctor of Nursing Practice
School of Nursing

Mary Bondmass, Ph.D.

Kathryn Hausbeck Korgan, Ph.D.

Examination Committee Chair

Graduate College Interim Dean

Rhigel Tan, DNP
Examination Committee Member

Lung-Chang Chien, DrPH
Graduate College Faculty Representative

ii

Abstract
The opioid epidemic is a national health emergency in the United States, with over 128
people dying each day due to an opioid overdose. It is estimated that 4.3 million people over the
age of 12 use opioids without a medical need, and 1.3 million youth ages 12-17 use opioids
inappropriately. Drug overdose deaths have become the leading cause of accidental death in the
United States, prompting the U.S. Surgeon General and the World Health Organization to advise
that more Americans have access to naloxone and understand how to use this life-saving drug
correctly. Naloxone is an opioid antagonist, used historically in medical settings over the last
five decades to reverse an opioid overdose in minutes; today, naloxone is available to anyone
using opioids or anyone who thinks they could encounter an opioid overdose.
Adults employed in rural public-schools may encounter a drug overdose through their
work with adults or adolescents. This possibility compelled the Elko County School District
(ECSD) to stock two doses of nasal naloxone (Narcan) in each school; however, a formal
naloxone training program was not implemented to educate staff about possible opioid risk or
naloxone administration. This educational need for opioid and naloxone training serves as the
impetus for this Doctor of Nursing Practice (DNP) project.
The purpose of this DNP project was to develop, implement, and evaluate an opioid risk
and naloxone training program for the ECSD nurses and school personnel. To achieve this
project’s purpose, the National Association of School Nurses (NASN) naloxone toolkit was
adapted and utilized to facilitate a voluntary online educational training session for all ECSD
school nurses and personnel meeting pre-determined inclusion criteria. This online training
module was offered through an e-mail invitation that was extended over approximately six
weeks. The training contained material to aid in recognizing opioid overdose, state and county-
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specific information about opioid overdose prevention and treatments, and protocols for
emergency response, including naloxone administration. A collection of demographic data and a
pre-post evaluation design were utilized to assess the knowledge and confidence levels before
and after implementing this training intervention.
One hundred fifty invitations were sent to participants via e-mail. Seventy-two possible
participants responded to the project’s invitation, but 42 did not complete all the project
requirements, and two were not working in the ECSD; therefore, 44 were excluded from all
analyses. The final sample included 28 (N = 28). The majority of responding participants were
female (N=19; 67.9%), mostly schoolteachers (N=12; 42.9%), and nurses (N=10; 36.7%). All
participants were full-time employees, and all worked in the ECSD. All participants were fulltime employees, and all worked in the ECSD. The results of the pre-and post-knowledge and
confidence assessments indicated a statistically significant improvement in both knowledge and
confidence. Self-reports indicated that the participants felt their learning needs were met and felt
improved confidence to respond during an overdose situation. These outcomes may also reveal
that educational reviews may be beneficial to school nurses and that with training, laypersons
can gain essential learning skills that resemble those of health professionals, allowing them to
respond effectively during an opioid overdose emergency. Finally, this project may imply that all
adults can benefit from this training module, especially those currently using opioids, those who
have previously used opioids with continued access to these drugs, or adults around others who
could be using these substances.
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Chapter I
Introduction
Nearly 50,000 Americans overdosed using opioid drugs in 2019; currently, it is estimated
that over 128 people die each day due to an opioid overdose (Center for Disease Control, 2020a;
National Institute on Drug Abuse, 2021). Opioids are mu-receptor agonists, a class of drugs used
medically to block the perception of pain. Opioids can produce feelings of pleasure, and over
time, they can create biological changes that lead to misuse, abuse, tolerance, dependence,
addictions, and increased risk of overdose, even in the presence of pain (Mazer- Amirshahi et al.,
2020; Volkow et al., 2019).
An opioid overdose death results from central nervous system (CNS) respiratory
suppression followed by cardiac arrest (Williams et al., 2019). The window to provide lifesaving treatment is limited and has historically relied on respiratory support alone or in
conjunction with cardiopulmonary resuscitation (CPR) in non-medical settings. In medical
settings, professionals have treated opioid-induced respiratory suppression by administering the
opioid antagonist drug naloxone since 1971 (Green et al., 2008; Volkow et al., 2019). Naloxone
(Narcan) is an antidote medication to opioid drugs, acting to compete for receptors in the brain to
block the opioid drug from binding, successfully reversing respiratory suppression (Williams et
al., 2019).
The goal of using opioid drugs effectively, without contributing to the opioid overdose
crisis, has incited policy reforms and the development of new healthcare initiatives (FeuersteinSimon et al., 2020; Wermeling, 2015). Efforts to improve education and access to naloxone have
saved over 10,000 lives and are estimated to save over 21,000 lives in ten years; thus, using
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naloxone is an essential method of opioid overdose prevention and treatment (Feuerstein-Simon
et al., 2020; Williams et al., 2019).
Problem and Significance
In 2017, the opioid epidemic was declared a national public health emergency, as drug
overdose deaths became the leading cause of accidental death, with opioid drug overdoses
accounting for 68% of that mortality rate (CDC, 2019b; Beheshti et al., 2015; Chisholm-Burns et
al., 2019). In Nevada, 372 opioid overdose deaths occurred in 2018; while data from 2019 has
yet to be released, the state was put on “red alert” for opioid overdose death risk as opioid
overdoses increased by 50% in the second quarter of 2020 (Department of Health and Human
Services, 2020; NIDA, 2020). Opioid overdose mortality rates are often up to 45% higher in
rural areas resulting from economic distress, overprescribing practices, a lack of treatment
facilities, and increased social isolation (Beheshti et al., 2015; Blue et al., 2021). Barriers to
opioid reversal in rural areas may include longer emergency response times and a lack of
supplies.
The number of opioids dispensed by prescribers can lead to the increased availability of
these drugs within communities. In Elko, Nevada, 12,086,020 opioid pills were dispensed with
prescriptions between 2006 and 2012, equating to roughly 36 opioid pills per person per year
(The Washington Post, 2019). Adults or adolescents may gain access to opioids through their
prescriptions, family prescriptions, or peer prescriptions. Those seeking these drugs can also
obtain illicit varieties through community acquaintances or online resources. Online resources
have become especially problematic in recent years because synthetic opioids, such as fentanyl,
may contain unknown substances and can be up to 50-100 times more potent than morphine or
heroin, increasing the risk of overdose (Volkow et al., 2019).
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An estimated 4.3 million people over the age of 12 use opioids without a medical need,
and 1.3 million youth ages 12-17 use opioids inappropriately (Brown, 2018; Welsh et al., 2018).
Access and misuse of prescription opioids can lead to addiction, followed by illicit opioid use,
increasing the risk of an adolescent overdose occurring within the school setting. The Elko
County School District (ECSD) performs annual emergency response training each year,
educating employees on recognizing and acting in health emergencies. Education on CPR,
administration of Epi-pens for anaphylaxis, and diabetic glucagon injection are reviewed;
however, formal opioid and naloxone training have not been initiated in this district.
Opioid overdose frequently occurs in front of a witness, or the victim is found by those
close to them, so improved community education can be a powerful tool to preventing overdose
(Feuerstein-Simon et al., 2020; Green et al., 2008). This information prompted the U.S. Surgeon
General to advise that more Americans have access to naloxone and understand how to use it
correctly (Williams et al., 2019). The World Health Organization (WHO) also addressed this
critical issue by launching recommendations stressing the importance of training and naloxone
access for any individual who could potentially encounter an opioid overdose victim (McDonald
& Strang, 2016; Follman et al., 2019). Since youth populations are not immune to the adverse
effects of opioid use and are known to misuse opioids, anticipating the potential of an overdose
in schools should be a priority in public education systems.
Improved understanding of the opioid risk and being aware of the correct administration
of naloxone are critical needs within any school district. The need to provide all school
personnel naloxone training is essential since the school nurse may be unavailable when an
overdose may occur. Opioid risk and naloxone training may enable adult witnesses of an
overdose to recognize warning signs and act appropriately in this emergency to prevent the
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tragedy of overdose death from occurring in the ECSD. Currently, each school within the ECSD
has access to naloxone; however, an educational training program regarding the issues associated
with opioid risks and the use of naloxone has not been approved or formally implemented; this
need served as the impetus for this proposed Doctor of Nursing Practice (DNP) project.
Purpose
The purpose of DNP project was to develop, implement, and evaluate an opioid risk and
naloxone administration training program for the ECSD administration and staff.
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Chapter II
Review of the Literature
This chapter will comprise a comprehensive review of the literature. A literature search
of numerous databases was completed to search for studies related to opioids, naloxone treatment
and training programs, and youth at risk in schools. Studies over the last two to three decades
were examined as this time frame coincides with the onset and drastic increase in opioid-related
deaths in the United States; however, the previous five years were of primary interest for this
project since the opioid crisis is always evolving, presenting new challenges and treatments.
The Cumulative Index of Nursing and Allied Health Literature (CINAHL), the Cochrane
Library, and MEDLINE through use of PubMed were searched using keywords, alone or in
combination, such as opioids, opiates, opioid overdose, opioid misuse, opioid abuse, substance
abuse, substance misuse, substance use disorder, opioid addiction, illegal opioid, prescription
opioid, opioid death, epidemic, drugs, narcotics, naloxone, Narcan, opioid and naloxone,
naloxone treatment, naloxone training, naloxone programs, Narcan administration, nasal
Narcan, naloxone and school, opioid antagonist, opioid and school, opioid and adolescents,
opioid protocols, opioid burden, opioid, and Nevada.
Opioid Action. Opiates are derived naturally from the opium poppy plant, while the
term opioids may include opiates, drugs created semi-synthetically, and drugs made synthetically
in labs around the world (Kunnumpurath et al., 2018). The opioid drug class includes both legal
drugs such as oxycodone, hydrocodone, morphine, tramadol, codeine, fentanyl, and illegal drugs,
including heroin and manufactured or synthetic fentanyl (NIDA, 2019). Opioids act in the brain
by binding to mu-receptors; this action blocks pain and releases dopamine, a natural
neurotransmitter the body produces in response to pleasurable activities. This rewarding
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response or “high” leads people to misuse opioids or start using opioids (Kosten & George,
2002). Mu-receptors are prevalent in the brain's reward networks, areas that regulate emotions,
and within the brainstem (Volkow et al., 2019). In addition to releasing dopamine, opioids
suppress noradrenaline. Noradrenaline is a chemical that stimulates breathing and wakefulness.
Over time the brain compensates, producing more of this chemical, leading to a state of normal
functioning with the opioid, and jitters, anxiety, muscle cramps, and diarrhea without the opioid
(Kosten & George, 2002).
These effects on the brain and body contribute to opioid tolerance or needing more of the
drug to get the same effect, and dependence, taking the drug to prevent withdrawal symptoms
(Kosten & George, 2002; Volkow et al., 2019). An estimated 21-29% or over 12 million people
misuse prescription opioids, and 8-12% of those will develop an opioid use disorder (ChisholmBurns et al., 2019; Kunnumpurath et al., 2018; NIDA, 2019). Misuse of opioids refers to taking
or using these medications differently from how they were prescribed (Volkow et al., 2019).
According to the CDC (2017c), the signs of opioid overdose “are pinpoint pupils,
excessive sleepiness or losing conscious, slow, shallow breathing with choking or gurgling, pale
blue or cold skin, and a limp body.” Opioid misuse is frequently a consequence of increased
availability of prescription opioid medications, a lack of opioid education, the false belief that
prescription medications are safe, mental health disorders, pain conditions, the prevalence of
illicit drugs, and the addictive nature of opioid substances (Williams et al., 2019).
Opioid History. The opioid epidemic has consisted of three distinct waves (CDC,
2020a; Florence et al., 2021). In the mid-1990s, several essential health organizations and the
pharmaceutical industry began working together to start campaigns to view pain as the fifth vital
sign in healthcare (Chisholm-Burns et al., 2019). Opioid risks were minimalized, and benefits
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were exaggerated in an effort to encourage the use of these medications for pain control. The
perceived minimized risk led to an increased dispensing of 164.8 million to 234 million for
immediate-release opioids and 9.3 million to 22.9 million for extended-release opioids
(Chisholm-Burns et al., 2019). Studies now show that the prevalence of early opioid abuse
directly correlated to the number of drugs being prescribed by providers (Brown, 2017; McCabe
et al., 2017). In 2010, synthetic opioid use started to rise, first with heroin and more recently
with fentanyl (CDC, 2020). Today, roughly 80% of Americans who use illicit opioids such as
heroin and fentanyl started this practice first by misusing prescription opioid medications, a
prevalent trend in young populations (Brown, 2017; McCabe et al., 2017; Chisholm-Burns et al.,
2019). Unfortunately, heroin and synthetic opioids remain less expensive and are readily
available to young people today, so while prescription opioid abuse has decreased slightly in
recent years, heroin and synthetic opioids such as fentanyl now account for more opioid
overdose deaths than prescription opioids (Volkow et al., 2019; Lambdin et al., 2018).
Opioid Burden. Costs related to the opioid epidemic continue to rise. The total
economic burden costs were estimated to be at just under 80 billion six years ago, with the
societal cost estimated at just over 55 billion over a decade ago (Brown, 2018; Meyers et al.,
2014). In 2017, healthcare costs, criminal misconduct, loss of productivity, reduced quality of
life, and the loss of life from opioid overdose death and opioid use disorders (OUD) increased
societal costs to an estimated 1.02 trillion dollars in the United States (Florence et al., 2021).
Over half of this estimated cost is attributed to overdose death. Loss of life before the age of 65
is estimated to be over 800,000 years, with those abusing drugs having eight times the direct
healthcare costs and 12 times as many hospital visits as non-abusers (Meyer et al. 2014). Opioid
use has more than doubled emergency room visits and doubled the number of those seeking
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treatment for OUD raising societal costs (Brown, 2018). A clinical burden is also profoundly felt
as more personnel and resources are needed to help individuals combating OUD and overdose
(Williams et al., 2019).
Opioid Intervention. Several policy changes and community programs have been
developed to inform providers, pharmacists, and patients of opioid risk. Providers and
pharmacists are required to check prescription drug monitoring programs to limit and validate
prescriptions. The drug enforcement administration reduced annual opioid drug manufacturing
by 20% in 2018 (Chisholm-Burns et al., 2019). Additionally, opioid prescriptions now have
daily limits, treatment contracts are being utilized between providers and patients, and ‘doctor
shopping’ laws are in place, making it illegal for patients to withhold information from their
providers (Chisholm-Burns et al., 2019). Medical professionals are encouraged to evaluate
individuals’ health literacy when providing opioid teaching and use teach-back methods to
ensure medication understanding (Chisholm-Burns et al., 2019). Community programs
encourage safe storage, safe drug disposal, drug take-back programs, take-home naloxone (THN)
programs, train the trainer programs (TT), and overdose education and naloxone distribution
programs (OEND) to prevent opioid overdose (Chisholm-Burns et al., 2019; Lambdin et al.,
2018). Many states within the United States, including Nevada, have implemented laws like the
Good Samaritan Overdose Act and 911 immunity laws to protect laypersons who administer
naloxone or call for help when they believe they are witnessing an opioid overdose (Nevada
Revise Statutes, 2020).
Treatment with Naloxone. Naloxone is a mu-opioid competitive receptor antagonist
drug approved for the treatment of opioid toxicity in 1971; it has been used from that time forth
by health professionals in treating accidental opioid overdoses (Shoup et al., 2020; Williams et
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al., 2019). Naloxone was endorsed for use in schools by the NASN in 2015, as it provides
school nurses with the ability to save a life in the event of an overdose (Welsh et al., 2018).
Naloxone can be given intravenously (IV), intramuscularly (IM), subcutaneously (SQ), or by the
intranasal (IN) route. Although IM and IN preparations are approved for use by laypersons, the
IN route is the preferred method of administration in the school environment as it is easy to
perform, effective, and has a reduced risk of a needle-stick injury (Welsh et al., 2018; Williams et
al., 2019). The recommended dose for IN administration is 2-4 mg, and the onset of actions
occurs within minutes, displacing the opioid drug from receptors in the brain to reverse
respiratory suppression (Lambdin et al., 2018; Williams et al., 2019). Of note, naloxone is a
short-acting medication with a 30-81-minute half-life, so it may need to be administered again in
the event respiratory suppression recurs (Beheshti et al., 2015; Wermeling, 2015). The chance of
recurrent respiratory suppression is higher with illicit opioid drugs as they have increased
potency and can outlast the effects of naloxone (Beheshti et al., 2015; Shaw et al., 2019). This
recurrent effect also makes transportation to a medical facility critical following overdose since
naloxone may need to be titrated with IV administration for longer-lasting results in preventing
overdose with potent opioids (Shaw et al., 2019). Ideally, naloxone is given to restore
spontaneous respiration, not full consciousness, as this scenario creates acute drug withdrawal
symptoms manifesting as anger and agitation on the part of the victim (Williams et al., 2019).
Naloxone Programs. In the United States, naloxone overdose prevention programs
consist of education and a naloxone kit; however, for many communities, access to the drug
naloxone remains lacking (Dreyfuss, 2015; Shoup et al., 2020). Barriers to naloxone prescribing
result from inadequate knowledge in medical and community settings, negative attitudes toward
naloxone distribution, and denial of risk by those using opioids (Shoup et al., 2020). Additional
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concerns related to naloxone use in communities have included cost, potential side effects, and
questionable knowledge of use by laypersons (Wilson et al., 2018). The opposition to naloxone
distribution also stems from fears that opioid drug abuse will increase, professional help may not
be sought in an overdose emergency, and ultimately respiratory suppression will recur (Beheshti
et al., 2015). While some of these fears can be valid, naloxone education and distribution
benefits typically outweigh the risks of naloxone administration by laypersons.
THN, TT, and OEND programs have been implemented in several countries and the
United States in response to the opioid crisis, resulting in a reported 26,460 overdose reversals
using naloxone (Devries et al., 2017). A study conducted by Neale et al. (2019) concluded that
an appropriate response to an opioid overdose required an increase in education and skills
through these training programs and the desire to help others in overdose emergencies. Another
study conducted by Green et al. (2008) concluded that people who have gone through naloxone
training programs are comparable to medical experts, consistently doing better to recognize and
treat opioid-related overdoses with the administration of naloxone.
Five decades of naloxone use in medical settings provided evidence that naloxone is a
safe drug to give. Adverse effects are minimal and predominantly outweigh the risks of death in
a potential overdose situation. A systematic review of THN programs showed that deaths from
overdose decreased with access to naloxone and that side effects of naloxone were typically
minimal, including reactions such as nausea, vomiting, diarrhea, body aches, anxiety, seizures,
and agitation (McDonald & Strang, 2016; Williams et al., 2019). According to Williams et al.
(2019), more severe reactions such as acute respiratory distress syndrome, hypertensive
emergencies, arrhythmias, or sudden death can occur, although this happens infrequently.
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Opioids Use in Schools. School teachers observe and know their students better than
other staff, so they will typically be the first to spot a change with a student. A Youth Risk
Behavior Survey found 21.7% of high school students had encountered illegal substances within
the previous year (Welsh et al., 2018). Educating teachers to recognize that sudden
hyperactivity, sleepiness, confusion, nausea or vomiting, constricted pupils, and difficulty
breathing are critical signs of substance abuse can provide early detection of a drug problem
(Welsh et al., 2018).
A longitudinal study, lasting over 40 years, revealed that those who had previously used
prescription opioids as students were more likely to go on to use prescription opioids for nonmedical purposes (McCabe et al., 2017). Non-medical use of opioids typically occurs with the
leftover portion of previous prescriptions and demonstrates that more education is needed
regarding the importance of proper disposal of unused medications. A survey of over 600 school
nurses found that 40% had encountered at least one or more students taking prescription opioids
for medical conditions such as fractures, dental procedures, and post-surgical pain (PattisonSharp et al., 2017).
Differences in opioid prescription use vary with gender, socio-economic situations, and
racial characteristics. McCabe et al. (2017) found that white male students are more likely than
female or African American students to use prescription opioids for non-medical purposes.
However, white female students are the most likely to obtain prescriptions for opioid
medications.
Students sharing drugs or taking opioids with alcohol or other drugs are other concerns
associated with opioid use, increasing the risk of death. McCabe et al. (2012) completed a study
that showed one out of eight high school seniors reported the non-medical use of prescription
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opioids, and 70% of those also ingested other drugs such as marijuana, alcohol, cocaine,
tranquilizers, and amphetamines at the same time. Although substance misuse was more
prevalent in high school students, information collected from rural middle schools demonstrates
that this population is also at risk of turning to prescription opioids and inhalants (Rose et al.,
2017).
Summary. The use of prescription opioids over the last 2-3 decades increased the notion
that opioid medications were safe and necessary in instances of pain. This mentality has
contributed to a rise in licit and illicit opioid misuse and the loss of thousands of lives. The
government and state agencies have created many measures to ensure providers and patients
know of the opioid risks; however, opioid misuse and overdose situations still plague many
communities throughout the United States. Continued access to licit and illicit opioids warrants
an ongoing effort in education and treatment for overdose prevention.
Overdose reversal with the use of naloxone toolkits has been proven an effective measure
in saving lives. Providing education and improving access to naloxone within community
settings, such as schools, can be an essential step toward preventing future overdose. Opioid
misuse is a problem in adolescent populations who are more likely to take risks with drugs, so it
would be necessary to educate those who interact with this population to recognize and treat any
student with signs and symptoms of an opioid overdose.
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Chapter III
Theoretical Underpinnings
This chapter presents the theoretical underpinnings of this DNP project. Kurt Lewin’s
Change Theory will guide this project’s intervention to increase opioid overdose awareness and
naloxone education for personnel within the ECSD. Lewin’s theory consists of three steps:
unfreezing, implementing changes, and re-freezing to change the status quo (Hussain et al.,
2018). Additionally, Albert Bandura’s Social-Cognitive Theory’s self-efficacy component will
guide this project in improving each participant’s confidence so they may act when faced with a
possible opioid overdose.
Lewin’s Change Theory. According to Lewin’s theory, the first necessary step will be to
“unfreeze” the current ideas and practices surrounding issues of opioid drug use and the potential
for an overdose in adolescent populations. Unfreezing will be done by applying external and
internal forces to gain approval for opioid and naloxone education from school administrators,
ultimately resulting in an organizational change (Hussain et al., 2018). Gathering information
through surveys specific to our district would demonstrate this issue’s prevalence and further
discussions on the importance of change. Applying transformational leadership principles and
using motivational communication with school personnel may encourage their support to make
proactive change possible (Hussain et al., 2018).
Implementing change, the second step in Lewin’s theory requires involvement on the part
of participants (Hussain et al., 2018). Utilizing the four concepts of power, information,
knowledge sharing, and rewards can facilitate employee involvement and generate new ideas for
consideration (Hussain et al., 2018). Information sharing on national and local data, including
prior survey results, would be shared during this time, along with information on the signs and
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symptoms of opioid overdose and naloxone administration. Practicing with nasal naloxone
dispensers on mannequins may improve and solidify knowledge and skills.
Lewin’s theory’s final step is to refreeze changes so people will not revert to the status
quo. Suggestions to refreeze changes include activity planning, commitment planning, and
change management structures (Hussain et al., 2018). Activity planning will consist of
completing annual training on opioid overdose and naloxone administration with this naloxone
toolkit used as a training guide. Demonstration and teach-back methods will be utilized with a
log to monitor those who have received training. According to Hussain et al. (2018), the
refreezing process can take the most time and is the least dramatic step of the 3-step change
process.
Self-Efficacy Theory. Bandura theorizes that it is not enough to possess the knowledge
and skill of what should be done; while that is important, individuals must also have a certain
level of self-efficacy or confidence to act in a difficult circumstance (Artino, 2012). This project
aims to provide a source for the increased knowledge and skill of responding to an opioid crisis.
However, having the confidence to perform during an opioid event will also rely on each
participant’s belief in their self-efficacy, so addressing this issue during the planning and
implementation phase of this project will be a significant way to maximize the outcomes of this
project.
Bandura theorized that there are four ways the perception of one’s self-efficacy is
transformed, these include: through one’s own experiences, through observing other’s
experiences, through another’s persuasion, and through the physiologic and emotional feedback
individuals give themselves during the performance of the task (Artino, 2012). While instructors
frequently utilize verbal persuasion in an academic setting, it is imperative to enhance the
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individual’s experience to build their self-efficacy of the task (Artino, 2012). Creating a learning
environment to build knowledge occurs by setting clear and specific goals, making the goals
challenging, albeit attainable, providing honest feedback, and providing examples (Artino,
2012). Applying these principles to this project can enhance the participant’s experience on this
subject and may facilitate improved self-efficacy, hereafter referred to as confidence, to respond
during any potential opioid emergency they encounter.
Summary. The ECSD has not initiated a plan to train on opioid drugs or naloxone
administration, so resistance to change and questions about whether this is a valid problem may
occur. The ECSD has naloxone available in each school, and some may think this is adequate
and only the school nurse’s responsibility. Addressing these questions will be important in the
unfreezing process. Motivating others to learn and desire further knowledge and skills in
response to a potential overdose will require discussion and knowledge sharing. Finally, some
may fear the responsibility of deciding when naloxone is appropriate and have a fear of
administering this medication. Bandura’s principles for improved self-efficacy will be applied to
the planning and implementation of this educational training program during the change process
to answer questions, increase experience, and alleviate fears associated with responding to an
overdose situation. The school nurse will be vital in improving confidence and ensuring a
refreezing of this change through the naloxone toolkit’s continued use to provide ongoing
education and guidance as this issue evolves in schools.
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Chapter IV
Project Proposal
This chapter describes how an opioid and naloxone training program was developed,
implemented, and evaluated for this DNP project. The setting and design, population, accessible
population and sample, project tasks, team, procedure, timeline, instruments, and outcome
variable are described. Data analysis, key stakeholders, and an organizational assessment,
resources and support, cost-benefit analysis, and risks and threats are also presented.
Setting and Design. The opioid overdose and naloxone training session’s initial location
was to be completed in a conference room in the ECSD’s main office building. After the initial
session was over, training was to occur at individual school building sites located throughout the
district; however, due to the COVID-19 pandemic, this project’s implementation was moved to
an online format, and the setting was therefore anywhere that a participant chose to access the
program. A pre-post evaluation design was utilized, assessing knowledge and confidence before
and after implementation of the intervention.
The Population, Accessible Population, and Sample. The population of interest included
all adults working in the ECSD in Nevada. The sample was one of convenience, and the size
was intended to be 50 – 75 total participants. The intent was to enroll 30 full-time Registered
Nurses (RN’s) and 20 – 30 teachers, aides, and administrators designated as school emergency
responders.
Although clinical relevance, rather than statistical significance, was sought, an a priori power
analysis based on the paired t-test was conducted to estimate the above-intended sample size.
G*Power 3.1.9.2 was utilized for this calculation which indicated at an estimated for a
conservative moderately small effect size of 0.35, type I error of 0.05, and 0.80 of power, 67
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participants would be needed. If a slightly higher effect size estimate (0.40) was utilized, 52
participants would be needed to have 0.80 of power. To reiterate, while statistical significance in
this quality improvement project was not primary in this design, it would serve to strengthen any
findings.
Inclusion criteria included:
•

Adults over the age of 18 years.

•

Employees of the ECSD

•

All participants would have CPR and first aid training

•

Have self-assessed willingness to participate in opioid and naloxone training and
to respond in overdose emergencies

Project Tasks. The project tasks needed for the DNP student to accomplish before the
intervention (training module) was implemented consisted of:
•

Obtain IRB approval

•

Develop the training presentation, including information specific to Nevada’s
state laws and policies

•

Prepare the online application (SurveyMonkey), including online pages for data
collection including, the demographic survey (Appendix A), the pre- and postassessments for knowledge and confidence (Appendix B), the training video
(Appendix C),

•

Supplemental educational materials (Appendix C) and the program’s evaluation
(Appendix D).
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•

Apply for continuing education units (CEU) for participating registered nurses
upon completing the training and a completion certificate for non-nursing
participants.

Team. This project’s team included the DNP student, the DNP Committee chairperson, the
DNP project committee, and the ECSD School Nurse Coordinator (SNC). The proposed role for
each team member is defined as follows:
•

The DNP student proposed this project in the spring 2020 semester. The DNP
student gained project approval from the University of Nevada, Las Vegas
Institutional Review Board (IRB) (Appendix F) in August 2020. The DNP
student implemented the project in December 2020. Results were analyzed and
compiled for the final doctoral defense scheduled for presentation in the spring
2021 semester.

•

The DNP project chairperson reviewed the DNP project over each semester and
acted as a mentor for basic statistics and project improvement until the final
project defense in the spring of 2021.

•

The DNP committee reviewed and approved the project proposal in the spring
2020 semester and will review the report for the final defense in spring of 2021.

•

The SNC provided early support and guidance to the DNP student through
reviewing and approving the proposed protocols and the presentation for school
staff training.

Procedure. Informed consent was obtained on the first page of the SurveyMonkey
application, which allowed for the use of the participants’ anonymous data/answers for this
project. Demographic, knowledge, and confidence data were collected; the former at the
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beginning of the program and the latter two assessments (knowledge and confidence) were
collected at pre-and post-intervention. Each participant entered their respective data directly on
the online application.
Intended Timeline.
•

IRB approval – summer 2020 semester

•

Project development – summer into fall 2020 semester

•

Data collection – November and December of 2020 (fall semester)

•

Data analysis – December 2020 (fall semester)

•

Project report preparation – January and February 2021 (spring semester)

•

Project defense – March 2021 (spring semester)

Instruments and Outcome Variables. This DNP project utilized and slightly adapted the
NASN naloxone toolkit for the video recording’s PowerPoint presentation (i.e., the intervention).
The NASN naloxone toolkit is in the public domain which can be downloaded for school nurse
leaders who are members of NASN. As a NASN member, the DNP student used this toolkit for
guidance to complete the training video for the participants. The kit also offers sample forms for
school district policy statements, a protocol and flowsheet for the use of naloxone, and a
naloxone administration reporting form. These forms will be implemented when in-person
classes begin on a consistent schedule. Although planned for this project, they will need to be
postponed and accomplished after the DNP student graduates.
This DNP project’s outcome was to increase each participant’s knowledge of opioid risk and
naloxone administration while also improving their confidence to respond to an opioid overdose
emergency. Participants in this DNP project completed pre-and post-intervention assessments to
determine whether the outcome was met. The DNP student developed the knowledge and
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confidence assessment, based primarily on the evidence available in the literature, by adapting
the New General Self Efficacy Scale (Appendix E) and using templates from the NASN toolkit.
Data Analysis. The project’s data were collected with a demographic survey (Appendix
B), and knowledge and confidence assessments were done at two measurement time-points (preand-post). Scores from the knowledge and confidence assessments were calculated with the
intent to compare pre-scores to post-scores. Data analyses were achieved utilizing SPSS 27;
descriptive statistics were computed for the demographic and program evaluation data
(frequencies and percentages), and the paired t-test was used for the pre and post scores for
knowledge (interval data); statistical significance was pre-determined to be less than 0.05.
Demographic data included age, race, gender, profession, years of experience, and time with the
ECSD, were analyzed with descriptive statistics, presented as frequencies and percentages.
Key Stakeholders. Key stakeholders include the ECSD, SNC, school administration,
school nurses, teachers, and the teacher’s union representative. Students and parents are also
considered stakeholders of this project. Vitality Unlimited, a non-profit, federally recognized
corporation in the community, may also be considered a stakeholder as this organization is
interested in increasing awareness of the use of naloxone and having donated naloxone to the
school district previously.
Organizational Assessment. An organizational assessment of the ECSD was conducted,
revealing 21 different school sites and 29 schools. This public-school district is the third-largest
in Nevada and covers the fourth largest geographical county in the contiguous 48 states.
Student’s current enrollment for the 2019-2020 school year is approximately 9,600 students, with
868 full-time employees, 224 part-time employees, and 263 substitute teachers. There is one
virtual school, while three others are one-room classroom schools in remote locations. Nineteen
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schools employ a full-time or part-time school nurse. These include four combined schools, nine
elementary schools, three middle schools, and three high schools. The School Nurse Coordinator
has two additional full-time RN’s that work as a procedure nurse and as a nurse who provides
coverage for each school as needed. Finally, there are three per diem nurses that work as
substitutes at schools throughout the district.
Resources and Support. The financial resources required to complete this DNP project
were minimal. The DNP student did not add to the expense since time, and educational sessions
were completed as a part of the DNP graduate program. The ECSD School Nurse Coordinator
supported this project and agreed to supply any paper necessary to distribute information and the
intended surveys; this support was not utilized due to the needed adaptation to an online format.
The ECSD was to absorb the cost of training employees by providing participants with a salary
or hourly rate pay, but again, this expense was not needed to complete this project due to the
online format.
Measures were taken to inform nurses and garner support from each school’s
administration by explaining the project’s purpose and intended benefits before the project
invitations were sent out.
Cost-Benefit Analysis. This DNP project’s costs were minimal; therefore, it was fiscally
feasible to implement and sustain throughout the district.
Risks and Threats. The risks and threats to successfully completing this DNP project
are essential to be considered and planned for; two significant risks are presented below.
The primary risk was thought to be low participation, given that the training was not
mandated, and most schools were not in session in-person. To mitigate this risk, continuing
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education units were offered to RN’s to encourage their participation, and ERT members earned
a certificate of attendance.
Another risk that was thought to possibly occur if participants did not demonstrate an
increase in knowledge and confidence levels. In this case, the project would be unlikely to have
an impact. To mitigate this risk, the information was presented utilizing adult learning
principles. The PowerPoint video was intended to be visually appealing, and the ‘take-home’
message was specific to the participants’ ‘real-life’ experience and practice.
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Chapter V
Results
This Doctor of Nursing Practice (DNP) project’s purpose was to develop, implement,
and evaluate an opioid risk and naloxone administration training program for the ECSD
administration and staff. This chapter presents the project’s results including, the sample
demographics, project’s outcome variables, and the participants’ evaluation of the project’s
module.
Sample Demographics
One hundred fifty invitations were sent to participants via e-mail. Seventy-two possible
participants responded to the project’s invitation, but 42 did not complete all the project
requirements, and two others were not working in the ECSD; therefore, 44 were excluded from
all analyses. The final sample included 28 (N = 28). The majority of responding participants
were female (19/67.9%), mostly schoolteachers (12/42.9%), and nurses (10/36.7). All
participants were full-time employees, and all worked in the ECSD. Table 1 presents a detailed
description of this sample’s demographics.

Table 1: Sample Characteristics

Age
Mean/SD
Min
Mode
Medium
Max

46.33±10.05
26
45.00
46.00
62
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Work Years (missing = 6)
Mean/SD
Min
Mode
Medium
Max

Nurses (n = 10)
16.3±11.34
2.0
32.00
15.50
32

Teachers (n = 12)
6.83±6.17
.1.0
5.0
5.0
21

Frequency

Percent

Female
Male
Preferred not to answer

19
8
1

67.9
28.6
3.6

Primary Role
School Teacher
Nurse
Administrator
Secretary

12
10
5
1

42.9
35.7
17.9
3.6

Employment status
Full time

28

100

Highest level of Education
Four or more years of
college with degree
Master’s degree

17
11

60.7
39.3

Previous naloxone training
Yes
No

15
13

53.6
46.4

Emergency Response Team
member
Yes
No
Not sure

23
2
3

82.1
7.1
10.7

Yes
No

4
24

14.3
85.7

Where naloxone was
administered (n = 4)
Hospital
Home (family member)
No answer

2
1
1

50.0
25.0
25.0

Gender

Administered naloxone
previously
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Outcome Variable: Knowledge
Participants in this DNP project completed pre-and post-intervention assessments to
determine whether the desired outcomes were met. The DNP student developed the knowledge
and confidence assessment, based primarily on the evidence available in the literature, and by
adapting the New General Self Efficacy Scale and using templates from the NASN toolkit.
The knowledge assessment was comprised of 20 questions. Each question was valued at
1 point, with a possible total score of 20. The confidence assessment consisted of 7 items, with
35 being the highest possible score. Significant differences in the mean pre- and post-knowledge
and confidence scores were found. Knowledge scores were 8.67 ± 2.79 compared to 12.48 ±
2.69; confidence scores were 25.75 ± 7.57 compared to 30.64 ±3.98. Figures 1 and 2 graphically
display the mean differences in the outcome variables.

Figure 1. Knowledge Assessment, (N=28)

Pre and Post Knowledge
14

*

12

Mean Scores

10
8
12.48

6
4

8.67

2
0
Pre

Post

*p-value < 0.0001
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Figure 2. Confidence Assessment, (N = 28)

Pre and Post Confidence
32

*

31

Mean Scores

30
29
28
27

30.64

26
25
24

25.75

23
Pre

Post

*p-value < 0.0001

Post Hoc Power Analysis
A post hoc power analysis with two tails, and alpha of 0.05 with a sample of 28 (df 27)
indicate the effect size was large at 0.55.
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Program Evaluation
Most responses on the program evaluation were positive; these data are below.

Table 2. Program Evaluation (n = 23)
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Chapter VI
Discussion
This chapter includes a discussion about the clinical relevance of this DNP project,
presents project limitations, relates project results to evidence and theory, considers the potential
for sustainability, implications for practice, and plans for utilization and dissemination of these
results.
Clinical Relevance. This DNP project is relevant to anyone currently using opioids,
those who have previously used opioids with continued access to these drugs, or adults around
others who could be using these substances. While the latter situation is impossible to discern,
opioid prescriptions are among the most prescribed medications in the United States, and illicit
substances are widely available, resulting in everyday opioid use among many. In Nevada,
opioid dispensing rates remain above the national average despite steady improvements over the
previous years. Dispensing rates correlate to the rate of opioid overdose, which has become the
number one cause of accidental deaths nationally, with over 128 opioid overdose deaths
occurring each day.
ECSD Schools. This online opioid and naloxone training provided a convenient and
cost-effective way to educate school personnel employed over a large geographical area in rural
Nevada. The ease of obtaining opioids and the misuse of opioids by adolescents over twelve
years is concerning. Still, the thought of an overdose may not occur to an untrained adult
responding to an overdose victim. This uncertainty may delay naloxone administration, wasting
valuable time. Furthermore, emergency response times in a rural area may be longer, increasing
mortality risk.
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Each school in the ECSD has two doses of naloxone (Narcan). This naloxone training
intervention may fill the gap to formally educate school staff on naloxone. Each public school
employs a nurse who may have some knowledge on opioids and naloxone; however, it is not
ideal to limit emergency training to one individual as there may be times that the nurse is
unavailable. Sick days, lunches, or after-school activities are examples of times when the nurse
may be unavailable. Training on CPR, glucagon, and epinephrine injections are given to the
ECSD employees who are designated as emergency responders (ERT) to anticipate other medical
emergencies where the nurse is unavailable, and training with naloxone is similarly essential.
Educating school personnel with this online training increased their knowledge and confidence to
recognize and respond to an opioid emergency and may also facilitate improved teamwork in an
opioid emergency.
Knowledge. Increased knowledge to recognize an opioid overdose and understanding
how to obtain naloxone for appropriate use was a desired outcome of this project. Twenty-eight
individuals completed a pre-and post-knowledge assessment which was created from the
presentation. The assessments were identical and applied to evaluate for improved knowledge.
The average amount of time each participant spent completing this training was one to two hours
which was expected. Forty-two people did not complete the training and typically ended their
training session within the first 30 minutes (two others completed but were not ECSD employees
and were excluded). The quantity of trainings remaining unfinished could reflect a lack of
motivation, disinterest, or uncontrolled interruptions. Partial trainings may also suggest that
condensing the training time may yield higher rates of completion; however, omitting
educational information may result in lower knowledge outcomes.
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Of the 28 who completed training, all except three improved in knowledge, as indicated
by their post-knowledge scores. These improved scores suggest that this online training
effectively increased opioid overdose and naloxone knowledge among nurses and ERT
personnel. Two participants’ pre- and post-knowledge scores remained the same, and one
person’s post-knowledge score decreased by one point. Explanations for this could include a
lack of full participation, misunderstanding the questions, or poorly phrased questions/answers.
Lastly, this online training intervention was accessed seventy-two times. It is unknown if
all who started the presentation began this training for the first time or if the training may have
been started more than once by the same person; however, the DNP student received e-mails
asking how to resume the training when the session was interrupted. These enquiries indicate
that some individuals may have chosen to start the training a second time or elected not to
complete the training since they would need to start over. Accessing the presentation numerous
times may impact knowledge assessment scores as trainees have more repetition and time to look
up answers from other sources.
Confidence. Being willing to help in an emergency may be an instinct for some
individuals; however, a person's confidence level may also motivate their ability to act in an
emergency. Improvement in individual confidence levels was an expected outcome of
participating in this training. The pre-confidence scores ranged from the lowest confidence level
to the highest confidence level. In the post-confidence assessment, all participants responded
with equal or higher confidence levels. These self-reported scores suggest that viewing this
online training increased individual confidence levels to respond in an opioid overdose event.
Therefore, this desired outcome was met with those who completed this training.
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Additional Thoughts. Those who completed this presentation felt that their learning
objectives were met and that the content used was appropriate for training on opioid and
naloxone use. The pre-knowledge and pre-confidence scores were higher for the school nurses
when compared to the ERT. This initial result is understandable since nurses may have received
prior opioid and naloxone training in nursing school, employment positions, or through selfstudy. Furthermore, nurses have become accustomed to responding in emergencies, as they are
trained for this role and often feel it is their duty. Interestingly, the nurse’s pre-knowledge scores
all showed some needs for improvement; however, the nurse’s pre-confidence scores revealed
high confidence levels. This scoring may reveal that the nurses believe they know about opioid
and naloxone information; however, gaps in knowledge may exist. These gaps may indicate that
annual reviews and ongoing education could be beneficial for school nurses.
While ERT members’ pre-knowledge and confidence scores were lower than the nurse
group, the post-knowledge and confidence scores for the ERT were within similar ranges to
many of the nurses. This outcome indicates that laypersons can achieve overdose response skills
comparable to medical professionals when they desire to help others and are provided with the
training. These outcomes support those previously reported by Neale et al. (2019) and Green et
al. (2008).
Finally, this training’s benefits extend into the community setting and are not limited to
the ECSD. One ERT member commented, “I wish I had gone through this program before my
daughter had an opioid overdose and required naloxone.” Another person wanted to verify the
procedure for obtaining naloxone through pharmacies due to their situation. The ECSD
encompasses a vast area with limited medical facilities, so supplying this education through the
school staff is another way to aid the community.
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Limitations. The number of participants was the primary limitation of this DNP project.
Although the ECSD enthusiastically approved this educational intervention at the time of the
project proposal, once the COVID-19 pandemic occurred, ECSD support diminished. The
project intervention planned for mandatory in-person instruction was adapted to an online
presentation that school staff could complete at their leisure.
Without the support to keep this instruction mandatory, many nurses and school staff
responded that they did not have time to complete the online training. Additionally, the fall
semester was a challenging time to implement this intervention since school instruction was all
held offsite and online. The absence of in-person schooling may have made the training seem
unnecessary since a school opioid overdose was unlikely to occur during this time. Furthermore,
an alternative in-person schedule was announced to begin in elementary schools and middle
schools while this project was open for participation which further limited participation as staff
reported feeling overwhelmed at this time. The project was open for participation for 6 weeks,
yet many expressed that they were unable to find time, so this may have been a limitation to the
project as well.
The online presentation’s length and the study format also may have limited participation
by ECSD employees. The instructions specified that training completion would take 1-2 hours;
however, it was also necessary to complete this intervention without ending the session. The
necessity to finish training at one time appeared to be a barrier to completion. The nurse and
school employees’ project attempts reveal that many individuals started the presentation,
sometimes more than once, yet they did not complete the final surveys to finish all the project
requirements. One person sent a message stating, “I have gained valuable information from this
training, unfortunately, I just do not have time to finish it.” Several participants sent emails
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asking how they could re-start the presentation where they left off and were disappointed when it
was communicated that they would be unable to resume at that same point due to the study’s
nature.
Finally, the inability to train the employees in-person limited this project’s outcomes.
The DNP student could not gauge individual learning needs or expound to clarify education as
necessary since the presentation was implemented online. Participants were unable to
communicate and share ideas with the instructor or one another to enhance learning. Questions
were encouraged in the written invitation emailed to participants, and the DNP student received
only the questions mentioned previously. Hands-on practice with naloxone trainers and takehome forms were expected to enhance learning, and this was unable to be performed from a
distance, so visual learning had to suffice, potentially limiting some learning.
Relationship of Project Results to Evidence and Theory. Lewin’s Change Theory was
applied to guide this project’s implementation. The first step was to unfreeze current practices
and support formal education on opioid and naloxone instruction for employees. Initially, the
SNC collaborated by offering suggestions and ideas for project planning, and the SNC approved
this project for the ECSD. Making this training mandatory for all school nurses and emergency
response teams was the SNC’s initial desire; however, this attitude evolved when the COVID-19
pandemic occurred. Further, a decision to change to an online format was met with minimal
opposition due to new protocols requiring social distancing and schools’ closure. The final
online presentation was viewed and approved by the SNC before implementation.
The second step of Lewin’s theory, implementation of the project, was set to begin before
school during the annual nurse training sessions. The school nurses’ involvement was an
essential step to starting this project; however, due to the COVID-19 pandemic, uncertainties
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about how school instruction would occur, and questions about whether the nurses would be
working full time, implementing the project was delayed. When it was realized that annual
training would not occur, the school nurses were contacted by e-mail and phone. The project
purpose was explained, each school nurse was requested to participate in the project, and they
were asked to be involved in supporting the project by providing the ERT names for their school.
Most of the nurses were very supportive; however, some were reluctant. One school nurse
responded to the invitation stating, “Sorry, the teachers are overwhelmed with school starting
soon, so I cannot put anything else on them right now.” Another nurse responded, “Please be sure
my staff members knows this is voluntary; they are all pretty stressed right now trying to get
ready for the kids to come back to school.” Gaining support from the nurse was crucial for their
participation and that of their school ERT. Therefore, continuing education credits and
completion certificates were accessible once the training was completed.
The final step consists of refreezing so that this formal training continues in practice. This
step requires planning. Further discussions to disseminate project results and reminders for to
add the opioid and naloxone training link to the district website are necessary. School nurses
would be made aware of the training link’s availability to help refer any staff who may be
interested or view it themselves if they were previously unable. Planning will also include
preparations for updating this training PowerPoint as necessary when information changes or
new content become available.
Bandura’s self-efficacy component acted as a guide to transforming confidence levels
when responding to an opioid overdose. This project intervention increased confidence by
supplying nurses and ERT with a learning experience and allowing them to view a simulated
example of someone reversing an overdose with naloxone. Although plans for experimenting
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with the hands-on naloxone trainers were not implemented, this suggestion may be included in
the future to improve confidence levels further. The ERT teams have volunteered to respond to
school crises, so supplying them with instruction and practice can improve their ability to
respond by building their confidence.
Potential for Sustainability. This project’s online training was an inexpensive and
convenient means to provide education and build confidence for ECSD employees who have
naloxone at their school. Incorporating this training for ongoing practice will be accomplished
by adding the training link to the ECSD website and including this school training presentation
in annual ERT training. This action provides continual access for anyone in the district who
wishes to complete this training or refresh their knowledge of opioids and naloxone.
To guarantee full participation and completion of this training by ERT, each school nurse
may consider scheduling a convenient time for ERT members in their school and proceed to lead
them through the training at the same time. Following this plan may assist the nurse and avoid
the limiting factors encountered with this DNP project. Meeting together would also allow
further discussion as a nurse would be available to answer questions that may arise, and the
training could include hands-on practice with naloxone trainers. In circumstances where
employees cannot attend the meeting in-person, completion of online training can be
accomplished from home. Scheduling this training annually in conjunction with CPR training
and other emergency training would ensure that opioid and naloxone training is maintained.
Furthermore, having the nurse present during this training would expand the nurse’s confidence
in her ERT members who may need to assist her in responding to an opioid emergency.
To maintain evidence-based training, the ECSD must recognize that the opioid crisis is a
rapidly evolving situation in the United States and globally. New information is continually
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circulated, so having a plan to keep the training current is critical. To ease this process, the
PowerPoint presentation used for this project will be given to the SNC to adjust and update each
year accordingly.
Implications for practice. This DNP project provided a way to educate ECSD
employees on opioid overdose and naloxone training formally. The results show a significant
increase in knowledge and confidence levels in both medical professionals and laypersons.
These outcomes validate performing annual emergency training with this online method and
allow ease of access anytime training is necessary throughout the district. The online format is
especially advantageous since long distances separate schools located in the ECSD, and school
nurses are only permitted to work a limited number of hours each day. These limiting factors
can make travel for training an issue for ECSD nurses.
In addition, this training will be accessible to anyone who has the internet and can access
the ECSD website, including parents. Since opioid use is a subject that is frequently stigmatized,
offering a link for free training may increase knowledge and confidence in community
populations that would otherwise be unwilling to express a need or interest.
Utilization and Dissemination of Results. These project results will be utilized and
disseminated to the ECSD with an executive summary. This summary will provide the SNC
feedback to understand how many nurses and ERT members participated in this DNP project and
will supply insight into its effectiveness. This summary will also equip the SNC with some ideas
for possible improvements during future training. Finally, distributing this summary to other
rural Nevada School Districts could also be beneficial.
This information will also be presented to other key stakeholder organizations in Nevada
and throughout the local community, including the Nevada Nurses Foundation, Vitality
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Unlimited, Humboldt General Hospital, Golden Health Family Medical Center, and Northeastern
Nevada Regional Hospital. Opportunities for submitting this information to journals concerned
with nursing, the opioid epidemic or youth populations will also be targeted to disseminate this
information.
Summary. Opioid overdoses occur throughout the United States daily, and rates have
remained steady or continued to rise in many areas despite enormous prevention efforts. Drug
overdose deaths are the number one cause of accidental death, and youth populations are not
immune. The euphoric high produced by opioids, their perceived safety, and their accessibility
leads to misuse of these drugs among youth. Furthermore, adolescents use drugs in combination
or develop drug addictions that lead them to use increasingly potent drugs, intensifying their risk
of a drug overdose and death.
Overdose death may transpire near friends, family, or anyone in close contact with the
individual; however, overdose signs may not be recognized or treated until too late. When
respiratory suppression ensues, a lack of oxygen may result in death. Historically these deaths
have been treated in the community setting with rescue breathing and CPR; however, these
rescue efforts are frequently ineffective.
Naloxone is the antidote drug to reverse opioid-related respiratory suppression. This
drug removes the opioid from mu receptors in the brain for a short time, allowing the signal to
breathe to return. Naloxone has been proven safe over five decades and produces minimal
effects on the body when an opioid is not present. Additionally, naloxone is easily administered
intranasally. In Nevada, laws exist to protect those who give naloxone in response to a perceived
opioid overdose victim.
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The ECSD recognizes that opioid overdose is a possible risk in the school setting and has
approved storing two doses of naloxone for rapid response in each school. Implementing formal
education and training to adults in each school permits an individual or team response in an
opioid overdose event and may increase the chance for survival and further drug treatment.
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Appendix A
Demographic Survey
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Appendix A
Demographic Survey (continued)
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Appendix A
Demographic Survey (continued)
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Appendix B
Pre and Post Knowledge and Confidence Assessment
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Appendix B
Pre and Post Knowledge and Confidence Assessment (continued)

43

Appendix B
Pre and Post Knowledge and Confidence Assessment (continued)
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Appendix B
Pre and Post Knowledge and Confidence Assessment (continued)
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Appendix B
Pre and Post Knowledge and Confidence Assessment (continued)
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Appendix C
Video Content Outline and Literature Citations
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Appendix C (continued)
Video Content Outline and Literature Citations
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Appendix C (continued)
Video Content Outline and Literature Citations
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Appendix C (continued)
Video Content Outline and Literature Citations
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Appendix C (continued)
Video Content Outline and Literature Citations

CLICK HERE TO BEGIN THE NALOXONE PRESENTATION
Optional Handout to use during the presentation
Required reading for all RNs - Article 1
Required reading for all RNs - Article 2
Required reading for all RNs - Article 3

Click here for the references used in the Naloxone Presentation

51

Appendix D
Program Evaluation
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Self-Efficacy Scale
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